NCT05320107View on ClinicalTrials.gov

The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Major Depressive Disorder
Interventions
DRUG

Ketamine

0.5mg/kg bodyweight (or 0.25mg/kg bodyweight) ketamine, will be determined in pilot study

DRUG

Placebo

0.9% NaCl

Trial Locations (1)

1090

RECRUITING

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER